{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T01:37:19Z","timestamp":1773884239035,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T00:00:00Z","timestamp":1485993600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s10096-017-2911-1","type":"journal-article","created":{"date-parts":[[2017,2,2]],"date-time":"2017-02-02T14:50:14Z","timestamp":1486047014000},"page":"1213-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications"],"prefix":"10.1007","volume":"36","author":[{"given":"B. A.","family":"Cunha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. B.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Giuga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Chin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. F.","family":"Zafonte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Gerson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,2]]},"reference":[{"key":"2911_CR1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.medmal.2013.01.006","volume":"43","author":"D Fournier","year":"2013","unstructured":"Fournier D, Chirouze C, Leroy J, Cholley P, Talon D, Plesiat P, Bertrand X (2013) Alernatives to carbapenems in ESBL-producing Escherichia coli infections. Med Mal Infect 43:62\u201366","journal-title":"Med Mal Infect"},{"key":"2911_CR2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/mdr.2012.0063","volume":"19","author":"BA Rogers","year":"2013","unstructured":"Rogers BA, Sidjabat HE, Silvey A, Anderson TL, Perera S, Li J, Paterson DL (2013) Treatment options for New Delhi metallo-beta-lactamase-harboring enterobacteriaceae. Microb Drug Resist 19:100\u2013103","journal-title":"Microb Drug Resist"},{"key":"2911_CR3","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00345-013-1031-5","volume":"31","author":"G Bonkat","year":"2013","unstructured":"Bonkat G, Muller G, Braissant O, Frei R, Tschudin-Suter S, Rieken M, Wyler S, Gasser TC, Bachmann A, Widmer AF (2013) Increasing prevalence of ciprofloxacin resistance in extended-spectrum-\u00df-lactamase-producing Escherichia coli urinary isolates. World J Urol 31:1427\u20131432","journal-title":"World J Urol"},{"key":"2911_CR4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.ajic.2014.06.013","volume":"42","author":"A Sorlozano","year":"2014","unstructured":"Sorlozano A, Jimenez-Pacheco A, de Dios Luna Del Castillo J, Sampedro A, Martinez-Brocal A, Miranda-Casas C, Navarro-Mari JM, Gutierrez-Fernandez J (2014) Evolution of the resistance to antibiotics of bacteria involved in urinary tract infection: a 7 year surveillance study. Am J Infect Control 42:1033\u20131038","journal-title":"Am J Infect Control"},{"key":"2911_CR5","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1179\/1973947814Y.0000000192","volume":"27","author":"QY Wang","year":"2015","unstructured":"Wang QY, Li RH, Shang XH (2015) Urinary tract infections caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns. J Chemother 27:117\u2013119","journal-title":"J Chemother"},{"key":"2911_CR6","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/AAC.01760-09","volume":"54","author":"S Auer","year":"2010","unstructured":"Auer S, Wojna A, Hell M (2010) Oral treatment options for ambulatory patients with urinary tract infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli. Antimicrob Agents Chemother 54:4006\u20134008","journal-title":"Antimicrob Agents Chemother"},{"key":"2911_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4161\/viru.23856","volume":"4","author":"CB Cunha","year":"2013","unstructured":"Cunha CB, Varughese CA, Mylonaskis E (2013) Antimicrobial stewardship programs (ASPs): the devil is in the details. Virulence 4:147\u2013149","journal-title":"Virulence"},{"key":"2911_CR8","doi-asserted-by":"crossref","unstructured":"Cunha BA (1988) Nitrofurantoin. Urol 32:67\u201371","DOI":"10.1016\/0090-4295(88)90460-8"},{"key":"2911_CR9","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1093\/jac\/dku282","volume":"69","author":"GV Sanchez","year":"2014","unstructured":"Sanchez GV, Am B, Karlowsky JA, Master RN, Bordon JM (2014) Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother 69:3259\u20133262","journal-title":"J Antimicrob Chemother"},{"key":"2911_CR10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1179\/joc.2011.23.3.171","volume":"23","author":"BA Cunha","year":"2011","unstructured":"Cunha BA (2011) Multidrug-resistant Gram-negative bacilli causing urinary tract infections: clinical considerations. J Chemother 23:171\u2013174","journal-title":"J Chemother"},{"key":"2911_CR11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/1120009X12Z.00000000013","volume":"24","author":"BA Cunha","year":"2012","unstructured":"Cunha BA, Schoch P, Hage JE (2012) Oral therapy of catheter associated bacteriuria (CAB) in the era of antibiotic resistance: nitrofurantoin revisited. J Chemother 24:12\u2013124","journal-title":"J Chemother"},{"key":"2911_CR12","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1201\/b13787-100","volume-title":"Kucers\u2019 the use of antibiotics","author":"ML Grayson","year":"2010","unstructured":"Grayson ML, Whitby M (2010) Nitrofurans: Nitrofurazone, Furazolidone and Nitrofurantoin. In: Grayson ML (ed) Kucers\u2019 the use of antibiotics, 6th edn. Arnold Hodder, London, pp 1195\u20131205","edition":"6"},{"key":"2911_CR13","first-page":"137","volume":"31","author":"EA Jackson","year":"1974","unstructured":"Jackson EA, McLeod DC (1974) Pharmacokinetics and dosing of antimicrobial agents in renal impairment. Am J Hosp Pharm 31:137\u2013148","journal-title":"Am J Hosp Pharm"},{"key":"2911_CR14","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.ajkd.2013.09.009","volume":"63","author":"A Farag","year":"2014","unstructured":"Farag A, Garg AX, Li L, Jain AK (2014) Dosing errors in prescribed antibiotics for older persons with CKD: a retrospective time series analysis. Am J Kidney Dis 63:422\u2013428","journal-title":"Am J Kidney Dis"},{"key":"2911_CR15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2215\/CJN.01931105","volume":"1","author":"DN Gilbert","year":"2006","unstructured":"Gilbert DN (2006) Urinary tract infections in patients with chronic renal insufficiency. Clin J Am Soc Nephrol 1:327\u2013331","journal-title":"Clin J Am Soc Nephrol"},{"key":"2911_CR16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jama.1961.03040130016004","volume":"175","author":"MW Woodruff","year":"1961","unstructured":"Woodruff MW, Malvin RL, Thompson IM (1961) The renal transport of nitrofurantoin. JAMA 175:1132\u20131135","journal-title":"JAMA"},{"key":"2911_CR17","first-page":"347","volume":"43","author":"BA Cunha","year":"1979","unstructured":"Cunha BA, Comer JB (1979) Pharmacokinetic considerations in the treatment of urinary tract infections. Conn Med 43:347\u2013353","journal-title":"Conn Med"},{"key":"2911_CR18","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/jac\/dku494","volume":"70","author":"P Komp Lindgren","year":"2015","unstructured":"Komp Lindgren P, Klockars O, Malmberg C, Cars O (2015) Pharmacodynamics studies of nitrofurantoin against common uropathogens. J Antimicrob Chemother 70:1076\u20131082","journal-title":"J Antimicrob Chemother"},{"issue":"731","key":"2911_CR19","first-page":"e1","volume":"84","author":"L Yang","year":"2014","unstructured":"Yang L, Wang K, Li H, Denstedt JD, Cadieux PA (2014) The influence of urinary pH on antibiotic efficacy against bacterial uropathogens. Urology 84(731):e1\u20137","journal-title":"Urology"},{"key":"2911_CR20","first-page":"103","volume-title":"Antibiotics essentials","year":"2015","unstructured":"Cunha BA (ed) (2015) Antibiotics essentials, 14th edn. Jay Pee Medical Publishers, New Delhi, pp 103\u2013105","edition":"14"},{"key":"2911_CR21","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archinte.164.15.1701-a","volume":"164","author":"CM Kunin","year":"2004","unstructured":"Kunin CM (2004) Inappropriate medication use in older adults: does nitrofurantoin belong on the list for the reason stated? Arch Intern Med 164:1701","journal-title":"Arch Intern Med"},{"key":"2911_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1345\/aph.1R352","volume":"47","author":"M Oplinger","year":"2013","unstructured":"Oplinger M, Andrews CO (2013) Nitrofurantoin contraindication in patients with a creatinine clearance below 60 ml\/min: looking for the evidence. Ann Pharmacother 47:106\u2013111","journal-title":"Ann Pharmacother"},{"key":"2911_CR23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00228-013-1520-x","volume":"69","author":"AF Geerts","year":"2013","unstructured":"Geerts AF, Eppenga WL, Heerdink R, Derijks HJ, Wensing MJ, Egberts TC, De Smet PA (2013) Ineffectiveness and adverse events of nitrofurantoin in woman with urinary and renal impairment in primary care. Eur J Clin Pharmacol 69:1701\u20131707","journal-title":"Eur J Clin Pharmacol"},{"key":"2911_CR24","doi-asserted-by":"crossref","unstructured":"Kashanian J, Hakimian P, Blute M Jr et al (2008) Nitrofurantoin: the return of an old friend in the wake of growing resistance. BJU Int 102:1634\u20131637","DOI":"10.1111\/j.1464-410X.2008.07809.x"},{"key":"2911_CR25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1179\/1973947814Y.0000000202","volume":"27","author":"BA Cunha","year":"2015","unstructured":"Cunha BA, Lee P, Kaouris N, Raza M (2015) The safety of nitrofurantoin for the treatment of nosocomial catheter-associated bacteriuria (CAB) and cystitis. J Chemother 27:122\u2013123, 2015","journal-title":"J Chemother"},{"key":"2911_CR26","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10096-016-2577-0","volume":"35","author":"BA Cunha","year":"2016","unstructured":"Cunha BA (2016) An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH. Eur J Clin Microbiol Infect Dis 35:521\u2013526","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2911_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-196501000-00001","volume":"44","author":"TA Stamey","year":"1965","unstructured":"Stamey TA, Govan DE, Palmer JM (1965) The localization and treatment of urinary tract infection: The role of bactericidal urine levels as opposed to serum levels. Medicine 44:1\u201336","journal-title":"Medicine"},{"key":"2911_CR28","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM197411282912204","volume":"291","author":"TA Stamey","year":"1974","unstructured":"Stamey TA, Fair WR, Timothy MM et al (1974) Serum versus urinary antimicrobial concentration in cure of urinary tract infections. NEJM 291:1159\u20131163","journal-title":"NEJM"},{"key":"2911_CR29","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1093\/infdis\/131.Supplement.S40","volume":"131","author":"DM Musher","year":"1975","unstructured":"Musher DM, Minuth JN, Thorsteinsson SB et al (1975) Effectiveness of achievable urinary concentrations of tetracycline against \u201ctetracycline resistant\u201d pathogenic bacteria. J Infect Dis 131:S40\u2013S44","journal-title":"J Infect Dis"},{"key":"2911_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000342423","volume":"90","author":"A Burian","year":"2012","unstructured":"Burian A, Erdogan Z, Jandrisits C et al (2012) Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine. Pharmacology 90:281\u2013287","journal-title":"Pharmacology"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-017-2911-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-017-2911-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T08:17:48Z","timestamp":1658564268000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-017-2911-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,2]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["2911"],"URL":"https:\/\/doi.org\/10.1007\/s10096-017-2911-1","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,2]]}}}